Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gülden Paçacı Çetin"'
Autor:
İnsu Yılmaz, Gülden Paçacı Çetin, Bahar Arslan, Serhat Şeker, Hatice Eylül Bozkurt Yılmaz, Elif Aktaş Yapıcı, Serpil Köylüce, Elif Açar
Publikováno v:
Tuberk Toraks. 71:75-93
Publikováno v:
Tuberkuloz ve toraks. 70(2)
Currently, there are four different diagnostic criteria systems for allergic bronchopulmonary aspergillosis (ABPA): The Rosenberg-Patterson, Seropositive ABPA (ABPA-S), Central Bronchiectasis and ABPA (ABPA-CB), and the International Society for Huma
Publikováno v:
International archives of allergy and immunology. 183(10)
Background: Although there are many studies presenting the efficacy of omalizumab in severe asthma, the data about the optimal treatment duration are still debated. Objective: In this study, we aimed to investigate the clinical effects of omalizumab
Publikováno v:
Tuberkuloz ve toraks. 69(4)
Macrolides are antibiotics with antiviral, anti-inflammatory and immunomodulatory effects in together with their bacteriostatic effects. In addition to its beneficial effects on chronic respiratory diseases such as COPD, cystic fibrosis, diffuse panb
Publikováno v:
European Journal of Clinical Nutrition. 75:1829-1831
Total parenteral nutrition (TPN) is a commonly used treatment method for patients whose oral intake is insufficient or who cannot use the gastrointestinal system. In the literature hypersensitivity reactions to contents of PN and fats are very rare.
Autor:
Sakine Nazik Bahçecioğlu, Murat Türk, Nuri Tutar, Gülden Paçacı Çetin, İnsu Yılmaz, Bahar Arslan
Publikováno v:
Turkish Journal of Medical Sciences
Background/aim The efficacy of mepolizumab has been largely demonstrated in clinical trials in patients with severe eosinophilic asthma (SEA). However, reports on experience with mepolizumab in a real-life cohort are limited. Moreover, data about the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee32be8afa4e3beb69e18a7e7e0dfc7
https://avesis.erciyes.edu.tr/publication/details/2fefe252-d199-4b95-8048-8455e023d384/oai
https://avesis.erciyes.edu.tr/publication/details/2fefe252-d199-4b95-8048-8455e023d384/oai
A very detailed differential diagnosis is necessary to investigate the causes of blood hypereosinophilia. In the differential diagnosis of hypereosinophilia with pulmonary involvement, primary and secondary eosinophilic lung diseases should be kept i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8baefe3c38b312f46bd54068b9f9c203
https://avesis.erciyes.edu.tr/publication/details/3a6389ad-c398-43e1-92e1-972e5cccddb0/oai
https://avesis.erciyes.edu.tr/publication/details/3a6389ad-c398-43e1-92e1-972e5cccddb0/oai
Autor:
Meryem Demir, Ceyda Tunakan Dalgic, Emine Nihal Mete Gokmen, Recep Savas, Suleyman Eroglu, Guzin Ozden, Cihan Orcen, Gulden Pacaci Cetin, Bahar Arslan, Ferda Bilgir, Gokten Bulut, Nurullah Yekta Akcam, Semiha Ozgul, Pamir Cerci, Raif Coskun, Sercan Gode, Insu Yilmaz, Aytul Zerrin Sin
Publikováno v:
Medicina, Vol 60, Iss 3, p 448 (2024)
Background and Objectives: Real-life data on the efficacy of biologic agents (BAs) on asthma-comorbid CRSwNP are needed. Our primary goal is to investigate the effects of BAs on CRSwNP symptoms, as well as endoscopic and tomography scores. Our second
Externí odkaz:
https://doaj.org/article/ae063b8ecc8d4221b7dbd69cdda3ee54